ALLERGIK OFTALMOPATOLOGIYALARDA OLOPATADIN GIDROXLORID 0.1% TARKIBLI KO’Z TOMCHISINI SAMARADORLIGINI BAHOLASH

ASL MANBA
Ushbu maqola dastlab CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE IN THE MODERN WORLD jurnalida nashr etilgan.

Yuldashov, Sarvarxon, Sodiqov, Abdulxamid (2024) ALLERGIK OFTALMOPATOLOGIYALARDA OLOPATADIN GIDROXLORID 0.1% TARKIBLI KO’Z TOMCHISINI SAMARADORLIGINI BAHOLASH. CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE IN THE MODERN WORLD, 1 (9). pp. 169-171.

[thumbnail of 169-171.pdf] PDF
169-171.pdf - Published Version

Download (548kB)

Annotatsiya

Butun jahon sog’liqni saqlash tashkiloti (BJSST) tomonidan oxirgi 10 yil davomida o’tkazilgan epidemiologik tadqiqotlar statistik xulosasi, allergik kasalliklar chastotasining global o'sishini qayd etdi [1,7,13]. Jahon allergiya tashkiloti (JAT)ning rasmiy bayonotiga ko’ra, hozirda umumiy allergozlar miqdori 3 barobar, xususan allergik oftalmopatologiyalar uchrashi 25% gacha ko’paygan [2,4]. Allergik ko'z kasalliklarining immunopatogenetik asosini gistamin (H) retseptorlari faollashishi va semiz hujayralarning degranulyatsiyasi tashkil qiladi [5,9,12]. Ushbu maqolaning asosiy maqsadi – oftalmologiya amaliyotida nisbatan yangi topikal antiallergik preparat - olopatadin gidroxlorid (Olopatadin 0.1% ko'z tomchisi) bo'yicha mavjud ilmiy adabiyotlarni ko'rib chiqish va tahlil qilish, shuningdek, klinik tadqiqot orqali Olopatadin 0.1% eritmasi preparatining samaradorligini baholash.

Hujjat turi: Maqola
Mualliflar:
Muallif
Email
Yuldashov, Sarvarxon
UNSPECIFIED
Sodiqov, Abdulxamid
UNSPECIFIED
Jurnal / Nashr: CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE IN THE MODERN WORLD
Jild: 1
Soni: 9
Sahifalar: pp. 169-171
Sana: 14 Oktabr 2024
Kalit so'zlar: allergik oftalmopatologiyalar; semiz hujayra; olopatadin gidroxlorid
URI: https://arxiv.universalpublishings.com/id/eprint/96756
Amallar
[pin missing: title]
[pin missing: title]